Q1 2025 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2025-05-15 · accession 0000938552-25-000003
$97.2M
Reported value
47
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 427746102 | HRTX | HERON THERAPEUTICS INC | $15.4M | 15.8% | 6,986,744 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $8.3M | 8.56% | 3,366,945 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $8.2M | 8.42% | 185,520 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $7.1M | 7.31% | 1,667,800 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $7.0M | 7.21% | 185,000 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $6.9M | 7.13% | 455,412 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $6.2M | 6.34% | 1,433,828 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $6.0M | 6.20% | 95,000 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $5.0M | 5.12% | 665,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $4.4M | 4.55% | 300,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.4M | 2.50% | 904,029 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $2.4M | 2.48% | 917,668 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $2.4M | 2.46% | 150,600 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $1.8M | 1.83% | 182,083 | Common | SOLE |
| 27966L306 | EDSA | EDESA BIOTECH INC | $1.7M | 1.73% | 687,500 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $1.2M | 1.23% | 69,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.2M | 1.19% | 400,000 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $1.1M | 1.13% | 323,973 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $1.1M | 1.10% | 500,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.0M | 1.07% | 655,000 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $1.0M | 1.06% | 153,500 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $911,840 | 0.94% | 747,410 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $896,896 | 0.92% | 111,972 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $670,118 | 0.69% | 1,030,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $654,840 | 0.67% | 107,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $545,831 | 0.56% | 83,333 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $367,891 | 0.38% | 122,223 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $313,290 | 0.32% | 59,000 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $140,000 | 0.14% | 80,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $105,040 | 0.11% | 13,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $82,500 | 0.08% | 75,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $68,500 | 0.07% | 50,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $67,650 | 0.07% | 55,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $60,200 | 0.06% | 28,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $59,850 | 0.06% | 45,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $55,080 | 0.06% | 90,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $54,040 | 0.06% | 14,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $53,550 | 0.06% | 35,000 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $47,685 | 0.05% | 75,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $46,920 | 0.05% | 17,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $46,000 | 0.05% | 40,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $38,760 | 0.04% | 12,000 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $38,150 | 0.04% | 35,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $30,254 | 0.03% | 97,000 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $28,875 | 0.03% | 35,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $12,008 | 0.01% | 25,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $11,660 | 0.01% | 45,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.